Office of the Director, National Institutes of Health: Notice of Meeting, 1390 [2023-00217]

Download as PDF 1390 Federal Register / Vol. 88, No. 6 / Tuesday, January 10, 2023 / Notices important to connect to the meeting by 3:45 p.m. to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. All participant audio lines will be muted for the duration of the meeting and only unmuted by the Host at the time of the participant’s public comment. Should you have questions during the session email napa@hhs.gov and someone will respond to your message as quickly as possible. In order to ensure accuracy, please submit a written copy of oral comments for the record by emailing napa@ hhs.gov by Wednesday, February 1, 2023. These comments will be shared on the website and reflected in the meeting minutes. In lieu of oral comments, formal written comments may be submitted for the record by Wednesday, February 1, 2023 to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to napa@ hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202–260–6075, helen.lamont@hhs.gov. Note: The meeting will be available to the public live at www.hhs.gov/live. Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: clinical care, dementia risk reduction, social determinants of health. Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer’s Project Act website when available, after the meeting. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. khammond on DSKJM1Z7X2PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: December 23, 2022. Benjamin Sommers, Senior Official Performing the Duties of the Assistant Secretary for Planning and Evaluation, Deputy Assistant Secretary for Health Policy. [FR Doc. 2023–00290 Filed 1–9–23; 8:45 am] BILLING CODE 4150–05–P VerDate Sep<11>2014 17:32 Jan 09, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Delegation of Authorities Notice is hereby given that I have delegated to the Administrator, Centers for Medicare & Medicaid Services (CMS) with authority to re-delegate the authorities vested in me as the Secretary of Health and Human Services pursuant to the Inflation Reduction Act (IRA, Pub. L. No: 117–169). The authority delegated is delineated in the following IRA provisions Sections 11001–11002: Drug Price Negotiation, 11101: Part B Inflation Rebate, and 11102: Part D Inflation Rebate. This delegation of authority would support the Federal Government’s efforts under the IRA to reduce prices for select high-cost drugs under Medicare Parts B and D (sections 11001–11004) and curb drug price increases to below the rate of inflation (sections 11101 and 11102). Without this delegation of authority, CMS would not be able to fully administer, implement, and operate these programs and initiatives consistent with the IRA. I hereby affirm and ratify any actions taken by the Administrator, CMS, or other CMS officials, which involve the exercise of these authorities prior to the effective date of this delegation. This delegation of authority is effective immediately. This delegation of authority may be re-delegated. This delegation of authority does not impact any other delegations of authority within CMS or in any other Department of Health and Human Services Operating Division or Staff Division. Dated: January 5, 2023. Xavier Becerra, Secretary. [FR Doc. 2023–00296 Filed 1–6–23; 4:15 pm] BILLING CODE 4150–03–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health: Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee to the Deputy Director for Intramural Research, National Institutes of Health. The meeting will be held as a virtual meeting and is open to the public as PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 indicated below. Individuals who plan to view the virtual meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the National Institutes of Health (NIH) Zoom website https://nih.zoomgov.com/ j/1605463562?pwd= TEgwWE9TNTlqUGg 5THFhbDhPWHJzUT09. Name of Committee: Advisory Committee to the Deputy Director for Intramural Research, National Institutes of Health. Date: February 2, 2023. Time: 10:00 a.m. to 4:00 p.m., EST. Agenda: The meeting will include a discussion of recruitment and retention of trainees and barriers thereto. Place: National Institutes of Health, 1 Center Drive, Building 1, Room 160, Bethesda, MD 20892 (Zoom Meeting). This meeting is a virtual meeting via Zoom and can be accessed at: https:// nih.zoomgov.com/j/1605463562?pwd= TEgwWE9TNTlqUGg 5THFhbDhPWHJzUT09. Meeting ID: 160 546 3562 Passcode: 448469 Dial by your location +1 669 254 5252 US (San Jose) +1 646 828 7666 US (New York) +1 551 285 1373 US +1 669 216 1590 US (San Jose) Join by SIP: sip: 1605463562@ sip.zoomgov.com. Join by H.323 161.199.138.10 (US West) 161.199.136.10 (US East) Meeting ID: 160 546 3562 Passcode: 448469 Contact Person: Margaret McBurney, Management Analyst, Office of the Deputy Director for Intramural Research, National Institutes of Health, 1 Center Drive, Room 160, Bethesda, MD 20892–0140, (301) 496–1921, mmcburney@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Office of Intramural Research home page: https://oir.nih.gov/sourcebook. Dated: January 4, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–00217 Filed 1–9–23; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\10JAN1.SGM 10JAN1

Agencies

[Federal Register Volume 88, Number 6 (Tuesday, January 10, 2023)]
[Notices]
[Page 1390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00217]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health: Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Advisory Committee to the Deputy Director for Intramural Research, 
National Institutes of Health.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting will 
be videocast and can be accessed from the National Institutes of Health 
(NIH) Zoom website https://nih.zoomgov.com/j/1605463562?pwd=TEgwWE9TNTlqUGg5THFhbDhPWHJzUT09.
    Name of Committee: Advisory Committee to the Deputy Director for 
Intramural Research, National Institutes of Health.
    Date: February 2, 2023.
    Time: 10:00 a.m. to 4:00 p.m., EST.
    Agenda: The meeting will include a discussion of recruitment and 
retention of trainees and barriers thereto.
    Place: National Institutes of Health, 1 Center Drive, Building 1, 
Room 160, Bethesda, MD 20892 (Zoom Meeting).

    This meeting is a virtual meeting via Zoom and can be accessed at: 
https://nih.zoomgov.com/j/1605463562?pwd=TEgwWE9TNTlqUGg5THFhbDhPWHJzUT09.
    Meeting ID: 160 546 3562
    Passcode: 448469
    Dial by your location

+1 669 254 5252 US (San Jose)
+1 646 828 7666 US (New York)
+1 551 285 1373 US
+1 669 216 1590 US (San Jose)

    Join by SIP: sip: [email protected].
    Join by H.323

161.199.138.10 (US West)
161.199.136.10 (US East)
Meeting ID: 160 546 3562
Passcode: 448469

    Contact Person: Margaret McBurney, Management Analyst, Office of 
the Deputy Director for Intramural Research, National Institutes of 
Health, 1 Center Drive, Room 160, Bethesda, MD 20892-0140, (301) 496-
1921, [email protected].
    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    Information is also available on the Office of Intramural Research 
home page: https://oir.nih.gov/sourcebook.

    Dated: January 4, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-00217 Filed 1-9-23; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.